60 related articles for article (PubMed ID: 25697374)
21. A double-blind, placebo-controlled study on the effects of lutein and zeaxanthin on photostress recovery, glare disability, and chromatic contrast.
Hammond BR; Fletcher LM; Roos F; Wittwer J; Schalch W
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8583-9. PubMed ID: 25468896
[TBL] [Abstract][Full Text] [Related]
22. Glare disability, photostress recovery, and chromatic contrast: relation to macular pigment and serum lutein and zeaxanthin.
Hammond BR; Fletcher LM; Elliott JG
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):476-81. PubMed ID: 23211814
[TBL] [Abstract][Full Text] [Related]
23. The ringlike structure of macular pigment in age-related maculopathy: results from the Muenster Aging and Retina Study (MARS).
Dietzel M; Zeimer M; Heimes B; Pauleikhoff D; Hense HW
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8016-24. PubMed ID: 21896850
[TBL] [Abstract][Full Text] [Related]
24. Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort.
Stringham JM; Garcia PV; Smith PA; McLin LN; Foutch BK
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7406-15. PubMed ID: 21296819
[TBL] [Abstract][Full Text] [Related]
25. The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS.
Nolan JM; Loughman J; Akkali MC; Stack J; Scanlon G; Davison P; Beatty S
Vision Res; 2011 Mar; 51(5):459-69. PubMed ID: 21237188
[TBL] [Abstract][Full Text] [Related]
26. The relationship between macular pigment and visual performance.
Loughman J; Akkali MC; Beatty S; Scanlon G; Davison PA; O'Dwyer V; Cantwell T; Major P; Stack J; Nolan JM
Vision Res; 2010 Jun; 50(13):1249-56. PubMed ID: 20394766
[TBL] [Abstract][Full Text] [Related]
27. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration.
Stringham JM; Hammond BR; Nolan JM; Wooten BR; Mammen A; Smollon W; Snodderly DM
Exp Eye Res; 2008 Nov; 87(5):445-53. PubMed ID: 18778703
[TBL] [Abstract][Full Text] [Related]
28. Spatial profile of macular pigment and its relationship to foveal architecture.
Nolan JM; Stringham JM; Beatty S; Snodderly DM
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2134-42. PubMed ID: 18436846
[TBL] [Abstract][Full Text] [Related]
29. The glare hypothesis of macular pigment function.
Stringham JM; Hammond BR
Optom Vis Sci; 2007 Sep; 84(9):859-64. PubMed ID: 17873771
[TBL] [Abstract][Full Text] [Related]
30. Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin.
Bone RA; Landrum JT; Cao Y; Howard AN; Alvarez-Calderon F
Nutr Metab (Lond); 2007 May; 4():12. PubMed ID: 17498306
[TBL] [Abstract][Full Text] [Related]
31. Macular pigment optical density and photophobia light threshold.
Wenzel AJ; Fuld K; Stringham JM; Curran-Celentano J
Vision Res; 2006 Dec; 46(28):4615-22. PubMed ID: 17087988
[TBL] [Abstract][Full Text] [Related]
32. Macular pigment: a review of current knowledge.
Whitehead AJ; Mares JA; Danis RP
Arch Ophthalmol; 2006 Jul; 124(7):1038-45. PubMed ID: 16832030
[TBL] [Abstract][Full Text] [Related]
33. Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods.
Trieschmann M; Heimes B; Hense HW; Pauleikhoff D
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1565-74. PubMed ID: 16642363
[TBL] [Abstract][Full Text] [Related]
34. Macular pigment shows ringlike structures.
Berendschot TT; van Norren D
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):709-14. PubMed ID: 16431971
[TBL] [Abstract][Full Text] [Related]
35. CFF thresholds: relation to macular pigment optical density.
Hammond BR; Wooten BR
Ophthalmic Physiol Opt; 2005 Jul; 25(4):315-9. PubMed ID: 15953116
[TBL] [Abstract][Full Text] [Related]
36. Spectral absorbance and spatial distribution of macular pigment using heterochromatic flicker photometry.
Wooten BR; Hammond BR
Optom Vis Sci; 2005 May; 82(5):378-86. PubMed ID: 15894914
[TBL] [Abstract][Full Text] [Related]
37. Heterochromatic flicker photometry.
Bone RA; Landrum JT
Arch Biochem Biophys; 2004 Oct; 430(2):137-42. PubMed ID: 15369810
[TBL] [Abstract][Full Text] [Related]
38. Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age-related eye disease study.
Snodderly DM; Mares JA; Wooten BR; Oxton L; Gruber M; Ficek T;
Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):531-8. PubMed ID: 14744895
[TBL] [Abstract][Full Text] [Related]
39. Macular pigment density and distribution: comparison of fundus autofluorescence with minimum motion photometry.
Robson AG; Moreland JD; Pauleikhoff D; Morrissey T; Holder GE; Fitzke FW; Bird AC; van Kuijk FJ
Vision Res; 2003 Jul; 43(16):1765-75. PubMed ID: 12818346
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
